Rising Cardiovascular Disease Prevalence and Advancements in Diagnostic Technologies Propel Market GrowthPune, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Cardiac Biomarker Testing Market Size & Growth Analysis ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...

Acute coronary syndrome (ACS) is a term used to describe a range of conditions resulting from the sudden reduction or ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

The following is a summary of “Prognostic role of cardiac and inflammatory biomarkers in extubation failure in patients with COVID-19 acute respiratory distress syndrome,” published in the January ...

Introduction: Atrial fibrillation (AF) is the most prevalent form of cardiac arrhythmia worldwide. Early diagnosis and treatment are essential, emphasizing the need to develop novel biomarkers.

Proenkephalin A 119-159 (penKid) demonstrates potential as a predictor for successful discontinuation of continuous renal ...

Integration and implications of biomarker data from pangenomes. Innovative methodologies in genetic, epigenetic, and proteomic analyses across different ethnic groups. We also invite submissions of ...

Recent comprehensive research analysis on Global burden of the Diseases for the period from 1990 to 2019 has identified ...

Background Acute kidney injury (AKI) in the context of acute decompensated heart failure (ADHF) encompasses a broad spectrum ...

Despite the lower ALS risk, heart and metabolism problems are tied to faster disease progression and worse survival in the ...

Capricor Therapeutics (CAPR) announced the completion of the submission of its Biologics License Application, BLA, to the U.S. Food and Drug ...